OTC Medication Information: Obagi Skintrinsiq Brightening Protocol

OBAGI SKINTRINSIQ BRIGHTENING PROTOCOL- homosalate, octisalate, and zinc oxide
Obagi Cosmeceuticals LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Obagi ® Sun Shield Matte Broad Spectrum SPF 50 Sunscreen

Drug Facts

Active ingredients Purpose
Homosalate 10% Sunscreen
Octisalate 5% Sunscreen
Zinc Oxide 16.5% Sunscreen

Uses

  • helps prevent sunburn
  • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only

Do not use on damaged or broken skin

Stop use and ask a doctor if rash occurs

When using this product keep out of eyes. Rinse with water to remove.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • apply liberally 15 minutes before sun exposure
  • use a water resistant sunscreen if swimming or sweating
  • reapply at least every 2 hours
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
    • limit time in the sun, especially from 10 a.m.–2 p.m.
    • wear long-sleeved shirts, pants, hats, and sunglasses
  • children under 6 months: Ask a doctor

Other information

  • store at controlled room temperature: 15°–25°C (59°–77°F)
  • protect this product from excessive heat and direct sun

Inactive ingredients

Water (Aqua), C15-19 Alkane, Octyldodecyl Neopentanoate, Polymethylsilsesquioxane, Sorbitan Olivate, Silica, Polyglyceryl-6 Polyrininoleate, Sodium Chloride, Xanthan Gum, Glycerin, Hydroxyacetophenone, Disodium EDTA, 1,2-Hexanediol, Caprylyl Glycol, Sodium Hydroxide, Triethoxycaprylsilane, Polyhydroxystearic Acid, Disteardimonium Hectorite, Polyglyceryl-2 Isostearate, Euphorbia Cerifera (candelilla) Wax, Beeswax, Dimethicone

Questions or comments?

1.800.636.7546

Monday–Friday 9 a.m.–4 p.m. Pacific Time

Distributed by Obagi Cosmeceuticals LLC, Long Beach, CA 90806

PRINCIPAL DISPLAY PANEL — Kit Carton

SKINTRINSIQ™

BRIGHTENING
PROTOCOL KIT

INCLUDES:

  • 60 Tips
  • Obagi Nu-Derm ® Gentle Cleanser, 2 FL. OZ.
  • Obagi Nu-Derm ® Toner, 2 FL. OZ.
  • Obagi Nu-Derm ® Clear Fx, 2 FL. OZ.
  • Obagi Hydrate ® Facial Moisturizer, 1.7 OZ.
  • Obagi Sun Shield™ Matte Broad Spectrum SPF 50 Sunscreen, 3 OZ.

OBAGI ®

PRINCIPAL DISPLAY PANEL -- Kit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 85 g Tube Carton

OBAGI ®
MEDICAL

Sun Shield

MATTE

Broad
Spectrum
SPF 50

Sunscreen
Lotion

Non-Comedogenic
Dermatologist Tested

Net wt. 3 oz (85 g)

PRINCIPAL DISPLAY PANEL -- 85 g Tube Carton
(click image for full-size original)
Established Pharmacological Class
Substance Pharmacological Class
Obagi Nu-Derm Gentle Cleanser Cleansing (cold creams, cleansing lotions, liquids, and pads)
Obagi Nu-Derm Toner Face and Neck (excluding shaving preparations)
Obagi Nu-Derm Clear Fx Face and Neck (excluding shaving preparations)
Obagi Hydrate Facial Moisturizer Moisturizing
OBAGI SKINTRINSIQ BRIGHTENING PROTOCOL
homosalate, octisalate, and zinc oxide kit
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:62032-905
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:62032-905-05 1 KIT in 1 BOX None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 BOTTLE, PLASTIC 60 mL
Part 2 1 BOTTLE, PLASTIC 59 mL
Part 3 1 BOTTLE, PLASTIC 57 g
Part 4 1 BOTTLE, PUMP 48 g
Part 5 1 TUBE 85 g
Part 1 of 5
OBAGI NU-DERM GENTLE CLEANSER
gel
Product Information
Route of Administration TOPICAL DEA Schedule
Ingredients
Ingredient Name Quantity
ALOE VERA LEAF
APRICOT KERNEL OIL
BORAGO OFFICINALIS SEED
BUTYLPARABEN
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)
COCAMIDOPROPYL BETAINE
DIETHYLENE GLYCOL MONOETHYL ETHER
ETHYLPARABEN
FD&C YELLOW NO. 5
GLYCERETH-7
GLYCERIN
ISOBUTYLPARABEN
METHYLPARABEN
OLEYL LACTATE
PANTHENOL
PHENOXYETHANOL
PROPYLPARABEN
SAGE
SODIUM LAURETH-3 SULFATE
SODIUM LAUROYL OAT AMINO ACIDS
TROLAMINE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 60 mL in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Cosmetic 08/01/2021
Part 2 of 5
OBAGI NU-DERM TONER
liquid
Product Information
Route of Administration TOPICAL DEA Schedule
Ingredients
Ingredient Name Quantity
ALLANTOIN
ALOE VERA LEAF
BORAGO OFFICINALIS SEED
CALENDULA OFFICINALIS FLOWER
DMDM HYDANTOIN
FD&C BLUE NO. 1
GLYCERIN
HAMAMELIS VIRGINIANA TOP WATER
IODOPROPYNYL BUTYLCARBAMATE
POLYSORBATE 80
POTASSIUM ALUM
SAGE
SODIUM PYRROLIDONE CARBOXYLATE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 59 mL in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Cosmetic 08/01/2021
Part 3 of 5
OBAGI NU-DERM CLEAR FX
lotion
Product Information
Route of Administration TOPICAL DEA Schedule
Ingredients
Ingredient Name Quantity
.ALPHA.-TOCOPHEROL ACETATE
ARBUTIN
ASCORBIC ACID
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
CETYL ALCOHOL
EDETATE DISODIUM ANHYDROUS
GLYCERIN
LACTIC ACID, UNSPECIFIED FORM
METHYLPARABEN
PROPYLPARABEN
SODIUM LAURYL SULFATE
SODIUM METABISULFITE
STEARYL ALCOHOL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 57 g in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Cosmetic 08/01/2021
Part 4 of 5
OBAGI HYDRATE FACIAL MOISTURIZER
lotion
Product Information
Route of Administration TOPICAL DEA Schedule
Ingredients
Ingredient Name Quantity
ALLANTOIN
AVOCADO OIL
CAESALPINIA SPINOSA RESIN
CAPRYLYL GLYCOL
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE
CETYL ALCOHOL
CYCLOMETHICONE 5
DIMETHICONE
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE)
ETHYLHEXYLGLYCERIN
GLYCERIN
GLYCERYL MONOSTEARATE
HEXYLENE GLYCOL
LAURETH-12
LEVOMENOL
MANGIFERA INDICA SEED BUTTER
MEDIUM-CHAIN TRIGLYCERIDES
PANTHENOL
PHENOXYETHANOL
SACCHARIDE ISOMERATE
SHEA BUTTER
SODIUM HYDROXIDE
SODIUM STEAROYL GLUTAMATE
SOY STEROL
SOYBEAN
STEARIC ACID
TETRAHYDRODIFERULOYLMETHANE
TOCOPHEROL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 1 BOTTLE, PUMP in 1 CARTON contains a BOTTLE, PUMP
1 48 g in 1 BOTTLE, PUMP This package is contained within the CARTON
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Cosmetic 08/01/2021
Part 5 of 5
SUN SHIELD BROAD SPECTRUM SPF 50 MATTE SUNSCREEN
homosalate, octisalate, and zinc oxide lotion
Product Information
Item Code (Source) NDC:62032-140
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HOMOSALATE (HOMOSALATE) HOMOSALATE 100 mg in 1 g
OCTISALATE (OCTISALATE) OCTISALATE 50 mg in 1 g
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE 165 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
1,2-HEXANEDIOL
C15-19 ALKANE
CANDELILLA WAX
CAPRYLYL GLYCOL
DIMETHICONE
DISTEARDIMONIUM HECTORITE
EDETATE DISODIUM ANHYDROUS
GLYCERIN
HYDROXYACETOPHENONE
OCTYLDODECYL NEOPENTANOATE
POLYGLYCERYL-2 MONOISOSTEARATE
POLYGLYCERYL-6 POLYRICINOLEATE
POLYHYDROXYSTEARIC ACID (2300 MW)
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
SILICON DIOXIDE
SODIUM CHLORIDE
SODIUM HYDROXIDE
SORBITAN OLIVATE
TRIETHOXYCAPRYLYLSILANE
WATER
XANTHAN GUM
YELLOW WAX
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:62032-140-09 1 TUBE in 1 CARTON contains a TUBE
1 85 g in 1 TUBE This package is contained within the CARTON (62032-140-09)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final M020 08/01/2021
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final M020 08/01/2021
Labeler — Obagi Cosmeceuticals LLC (790553353)
Establishment
Name Address ID/FEI Operations
G.S.COSMECEUTICAL USA, INC. 017014734 manufacture (62032-905)
Establishment
Name Address ID/FEI Operations
Denison Pharmaceuticals, LLC 001207208 manufacture (62032-905)
Establishment
Name Address ID/FEI Operations
Swiss-American CDMO, LLC 080170933 manufacture (62032-905)
Establishment
Name Address ID/FEI Operations
TENCO ASSEMBLIES, INC 075535609 pack (62032-905)

Revised: 03/2023 Obagi Cosmeceuticals LLC

Our database comes directly from the FDA’s central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA’s repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2024. All Rights Reserved.